Nachman Norwood & Parrott’s Surmodics SRDX Stock Holding History

Nachman Norwood & Parrott’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,478	Closed	-$58K	–	934
2020 Q3	$58K	Buy	+1,478	New	+$64.9K	0.01%	414

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Nachman Norwood & Parrott's SRDX Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Surmodics (SRDX) in Q4 2020, closing a stake of 1,478 shares — an estimated $58K sold.

Nachman Norwood & Parrott first reported a position in SRDX in Q3 2020 and held it in 1 quarter. The position peaked at $58K in Q3 2020. 140 funds tracked by Wall St. Rank hold SRDX as of Q4 2020.

Nachman Norwood & Parrott reported no remaining Surmodics position as of Q4 2020 after selling out during the quarter.
Nachman Norwood & Parrott sold 1,478 Surmodics shares in Q4 2020, an estimated $58K.
Nachman Norwood & Parrott first reported a position in Surmodics in Q3 2020 and held it in 1 quarter.
Nachman Norwood & Parrott's Surmodics position peaked at $58K in Q3 2020.
140 funds tracked by Wall St. Rank held Surmodics as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.